After a year of electrifying returns, is AppLovin still a ticket to growth, or has the ship already sailed?

Adobe’s latest quarterly results have left investors underwhelmed. With the stock under pressure and uncertainty looming, is it time to buy, sell, or hold Adobe shares?

With Benchmark analysts giving Rivian a bullish nod, would it be wise for investors to jump in and position themselves for potential gains next year?

While Alphabet faced some major setbacks amid regulatory hurdles this year, would it be wise to load up its shares as it regains momentum thanks to its latest exciting innovations?

After delivering electrifying returns this year thanks to key growth catalysts, is it too late to get in on this AI growth stock now?

Analysts are bullish on these three mega-cap tech names, making them wise picks for investors.

As AI fuels an unprecedented boom in data center demand, here’s a closer look at three data center stocks that have recently posted stellar quarterly earnings reports.

With the growing demand for cutting-edge therapies reshaping the healthcare landscape, here are two “Strong Buy”-rated biotech stocks with significant potential upside.

With Warren Buffett’s partial exit and growing skepticism from analysts like Citi, this fintech darling is facing mounting doubts about its future growth potential.

With 2024 nearing its finale, here are three budget-friendly stocks to consider this month for potential gains.